surmount-1 trial tirzepatide non-diabetic obesity weight loss In the (published in NEJM in July 2022) in participants with #obesity, 5 mg, 10 mg, or 15 mg of once weekly provided substantial and sustained reductions in body weight. Discussing Promising New Findings Easy Touch Quantity:1 Bottle (30 Day Supply)

surmount-1 trial tirzepatide non-diabetic obesity weight loss In the (published in NEJM in July 2022) in participants with #obesity, 5 mg, 10 mg, or 15 mg of once weekly provided substantial and sustained reductions in body weight. Discussing Promising New Findings Easy Touch Quantity:1 Bottle (30 Day Supply)

Discussing Promising New Findings on GLP-1 Use in Psoriasis Management, With Neal Bhatia, MD

Avoid placing your medication directly on ice packs to prevent freezing

Easy Touch

Quantity:1 Bottle (30 Day Supply)

Regular check-ins assess progress and tolerability, ensuring your treatment plan supports your personal weight-loss goals